|
1
|
World Health Organization: Clinical
Management of Severe Acute Respiratory Infection when Novel
Coronavirus (nCoV) Infection is Suspected: Interim Guidance.
January 11, 2020.
|
|
2
|
World Health Organization: Coronavirus
Disease 2020 (COVID-19) Pandemic. 16 December, 2020. Available
from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
|
|
3
|
National Health Commission of the People's
Republic of China: China's Novel Coronavirus Pneumonia Diagnosis
and Treatment Plan (Trial version 7). March 3, 2020. Available
from: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
|
|
4
|
Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L,
Xu T, Jiang YZ, Xiong Y, Li YJ, Li XW, et al: Identification of a
novel coronavirus causing severe pneumonia in human: A descriptive
study. Chin Med J (Engl). 133:1015–1024. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Fan Y, Zhao K, Shi ZL and Zhou P: Bat
Coronaviruses in China. Viruses. 11(210)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ye ZW, Yuan SF, Yuen KS, Fung SY, Chan CP
and Jin DY: Zoonotic origins of human coronaviruses. Int J Biol
Sci. 16:1686–1697. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
in-fected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bourgonje AR, Abdulle AE, Timens W,
Hillebrands JL, Navis GJ, Gordijn SJ, Bolling MC, Dijkstra G, Voors
AA, Osterhaus AD, et al: Angiotensin-converting enzyme 2 (ACE2),
SARS-CoV-2 and the pathophysiology of corona-virus disease 2019
(COVID-19). J Pathol. 251:228–248. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan
B, Huan Y, Yang P, Zhang Y, Deng W, et al: A crucial role of
angi-otensin converting enzyme 2 (ACE2) in SARS coronavirus-induced
lung injury. Nat Med. 11:875–879. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Rabaan AA, Al-Ahmed SH, Haque S, Sah R,
Tiwari R, Malik YS, Dhama K, Yatoo MI, Bonilla-Aldana DK and
Rodriguez-Morales AJ: SARS-CoV-2, SARS-CoV, and MERS-COV: A
comparative overview. Infez Med. 28:174–184. 2020.PubMed/NCBI
|
|
12
|
Goumenou M, Sarigiannis D, Tsatsakis A,
Anesti O, Docea AO, Petrakis D, Tsoukalas D, Kostoff R, Rakitskii
V, Spandidos DA, et al: COVID 19 in Northern Italy: An integrative
overview of factors possibly influencing the sharp increase of the
outbreak (Review). Mol Med Rep. 22:20–32. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Petrakis D, Margină D, Tsarouhas K, Tekos
F, Stan M, Nikitovic D, Kouretas D, Spandidos DA and Tsatsakis A:
Obesity a risk factor for increased COVID 19 prevalence, severity
and lethality (Review). Mol Med Rep. 22:9–19. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Goumenou M, Spandidos DA and Tsatsakis A:
[Editorial] Possibility of transmission through dogs being a
con-tributing factor to the extreme Covid 19 outbreak in North
Italy. Mol Med Rep. 21:2293–2295. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhou P, Yang X, Wang X, Hu B, Zhang L,
Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al: Discovery of a novel
coronavirus associated with the recent pneumonia outbreak in humans
and its potential bat origin. Nature: Jan 23, 2020 (Epub ahead of
print). doi: 10.1038/s41586-020-2012-7.
|
|
16
|
Meyerholz DK, Lambertz AM and McCray PB
Jr: Dipeptidyl peptidase 4 distribution in the human respiratory
tract: Implications for the Middle East respiratory syndrome. Am J
Pathol. 186:78–86. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tao JL, Wang AX, Guan CL, et al:
Protein-protein docking research on spike protein of three
human-coronavirus and its receptors. J Logis Univ CPAPF.
26:392–396. 2017.
|
|
18
|
Chinese Medical Association, China
Association of Chinese Medicine. Diagnosis and treatment of severe
acute respiratory syndrome (SARS). Chin Med J (Engl). 83:1731–1752.
2003.
|
|
19
|
van den Brand JM, Smits SL and Haagmans
BL: Pathogenesis of Middle East respiratory syndrome coronavirus. J
Pathol. 235:175–184. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Alsaad KO, Hajeer AH, Al Balwi M, Al
Moaiqel M, Al Oudah N, Al Ajlan A, AlJohani S, Alsolamy S, Gmati
GE, Balkhy H, et al: Histopathology of Middle East respiratory
syndrome coronovirus (MERS-CoV) infection - clinico-pathological
and ultrastructural study. Histopathology. 72:516–524.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xu Z, Shi L, Wang Y, Zhang J, Huang L,
Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al: Pathological findings
of COVID-19 associated with acute respiratory distress syndrome.
Lancet Respir Med. 8:420–422. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Magro C, Mulvey JJ, Berlin D, Nuovo G,
Salvatore S, Harp J, Baxter-Stoltzfus A and Laurence J: Complement
associated microvascular injury and thrombosis in the pathogenesis
of severe COVID-19 infection: A report of five cases. Transl Res.
220:1–13. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wei PF: National Health Commission and
National Administration of Traditional Chinese Medicine. Diagnosis
and treatment of novel coronavirus pneumonia (Trial version 7).
Chin Med J. 133:1087–1095. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang MQ, Wang XH, Chen YL, Zhao KL, Cai
YQ, An CL, Lin MG and Mu XD: Clinical features of 2019 novel
coronavirus pneumonia in the early stage from a fever clinic in
Beijing. Zhonghua Jie He He Hu Xi Za Zhi. 43:215–218.
2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
25
|
Guideline for medical imaging auxiliary
diagnosis of coronavirus disease 2019. Zhongguo Yi Xue Ying Xiang
Ji Shu. 36:321–330. 2020.(In Chinese).
|
|
26
|
Chinese Medical Association, Chinese
Medical Doctor Association, China Research Hospital Association.
Diagnostic guidelines for novel coronavirus pneumonia (2020 Version
1). New Med (Wars). 30:22–34. 2020.
|
|
27
|
de Groot RJ, Baker SC, Baric RS, Brown CS,
Drosten C, Enjuanes L, Fouchier RA, Galiano M, Gorbalenya AE,
Memish ZA, et al: Middle East respiratory syndrome coronavirus
(MERS-CoV): Announcement of the Coronavirus Study Group. J Virol.
87:7790–7792. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhu FQ and Lee G: Middle East respiratory
syndrome. J Clin Inter Med. 33:91–93. 2016.
|
|
29
|
Meng JG and Lee YQ: Symptoms, imaging and
laboratory diagnosis of Middle East respiratory syndrome. Zhonghua
Linchuang Yishi Zazhi. 43:3–5. 2015.
|
|
30
|
Drosten C, Seilmaier M, Corman VM,
Hartmann W, Scheible G, Sack S, Guggemos W, Kallies R, Muth D,
Jun-glen S, et al: Clinical features and virological analysis of a
case of Middle East respiratory syndrome coronavirus in-fection.
Lancet Infect Dis. 13:745–751. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A
and Madani TA: Middle East respiratory syndrome coronavirus
(MERS-CoV) infection: Chest CT findings. AJR Am J Roentgenol.
203:782–787. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Das KM, Lee EY, Enani MA, AlJawder SE,
Singh R, Bashir S, Al-Nakshbandi N, AlDossari K and Larsson SG: CT
correlation with outcomes in 15 patients with acute Middle East
respiratory syndrome coronavirus. AJR Am J Roentgenol. 204:736–742.
2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhong NS: Diagnosis and treatment of SARS.
Chin J Med. 83:95–116. 2003.
|
|
34
|
Choi WJ, Lee KN, Kang EJ and Lee H: Middle
East Respiratory Syndrome-Coronavirus Infection: A case report of
serial computed tomographic findings in a young male patient.
Korean J Radiol. 17:166–170. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Hijawi B, Abdallat M, Sayaydeh A,
Alqasrawi S, Haddadin A, Jaarour N, Alsheikh S and Alsanouri T:
Novel coronavirus infections in Jordan, April 2012: Epidemiological
findings from a retrospective investigation. East Medi-terr Health
J. 19 (Suppl 1):S12–S18. 2013.PubMed/NCBI
|
|
36
|
Chen S and Chen MQ: The recent progress on
clinical control for Middle East respiratory syndrome. J Micro
Infect. 10:208–214. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
WHO Mers-Cov Research Group: State of
knowledge and data gaps of middle east respiratory syndrome
coronavirus (MERS-CoV) in humans. PLoS Curr: Nov 12,2013 (Epub
ahead of print). doi:
10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8.
|
|
38
|
Nowotny N and Kolodziejek J: Middle East
respiratory syndrome coronavirus (MERS-CoV) in dromedary camels,
Oman, 2013. Euro Surveill. 19(20781)2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He
JX, Liu L, Shan H, Lei CL, Hui DS, et al: Clinical Characteristics
of Coronavirus Disease 2019 in China. N Engl J Med. 382:1708–1720.
2020.
|
|
40
|
Yang Y, Lu QB, Liu MJ, Wang YX, Zhang AR,
Jalali N, Dean NE, Longini I, Halloran ME, Xu B, et al:
Epidemiological and clinical features of the 2019 novel coronavirus
outbreak in China. medRxiv: Feb 11, 2020 (Epub ahead of print).
doi: org/10.1101/2020.02.10.20021675.
|
|
41
|
Peiris JS, Chu CM, Cheng VC, Chan KS, Hung
IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, et al: HKU/UCH SARS
Study Group: Clinical progression and viral load in a community
outbreak of corona-virus-associated SARS pneumonia: A prospective
study. Lancet. 361:1767–1772. 2003.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lapinsky SE and Hawryluck L: ICU
management of severe acute respiratory syndrome. Intensive Care
Med. 29:870–875. 2003.PubMed/NCBI View Article : Google Scholar
|
|
43
|
World Health Organization: State of
knowledge and data gaps of Middle East respiratory syndrome
coronavirus. Available from: http://www.who.int/csr/disease/coronavirus_infections/en.
|
|
44
|
Saad M, Omrani AS, Baig K, Bahloul A,
Elzein F, Matin MA, Selim MA, Al Mutairi M, Al Nakhli D, Al
Ai-daroos AY, et al: Clinical aspects and outcomes of 70 patients
with Middle East respiratory syndrome coronavirus infection: A
single-center experience in Saudi Arabia. Int J Infect Dis.
29:301–306. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lu PX, Yang GL, Yu WY, et al: Imaging
follow-up of SARS patients complicated with pulmonary fibrosis.
Chin J Med Imaging Tech. 20:1901–1903. 2004.
|
|
46
|
Kong Q and Qin C: Comparative study on
pathogenesis of SARS pulmonary fibrosis. Chin J Comp Med.
15:335–338. 2005.
|
|
47
|
Lei J, Li J, Li X and Qi X: CT Imaging of
the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology.
295(18)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Vandenberg O, Martiny D, Rochas O, van
Belkum A and Kozlakidis Z: Considerations for diagnostic COVID-19
tests. Nat Rev Microbiol. 14:1–13. 2020.
|
|
49
|
Hoque MN, Chaudhury A, Akanda MA, Hossain
MA and Islam MT: Genomic diversity and evolution, diagno-sis,
prevention, and therapeutics of the pandemic COVID-19 disease.
PeerJ. 8(e9689)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Shang L, Zhao J, Hu Y, Du R and Cao B: On
the use of corticosteroids for 2019-nCoV pneumonia. Lancet.
395:683–684. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
World Health Organization: Clinical
management of severe acute respiratory infection when novel
coronavirus (nCoV) infection is suspected. Available from:
https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novelcoronavirus-(ncov)-infection-is-suspected.
|
|
52
|
Du B, Qiu HB, Zhan X, Wang YS, Kang HY, Li
XY, Wang F, Sun B and Tong ZH: Pharmacotherapeutics for the new
coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43:173–176.
2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
53
|
Koo HJ, Lim S, Choe J, Choi SH, Sung H and
Do KH: Radiographic and CT features of viral pneumonia.
Radiographics. 38:719–739. 2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Guo YB: Clinical classification and early
warning indicators of SARS. Chin Med News. 18:7. 2003.
|
|
55
|
Tongji Hospital Affiliated to Tongji
Medical College of Huazhong University of Science and Technology,
Peking Union Medical College Hospital, China-Japan Friendship
Hospital. Diagnosis, treatment and management of the severe type of
novel coronavirus pneumonia (Novel Coronavirus Pneumonia Treatment
Cooperation Group of Tongji Hospital). J Inter Inten Med. 26:1–5.
2020.
|
|
56
|
Shi F, Yu Q, Huang W and Tan C: 2019 Novel
Coronavirus (COVID-19) pneumonia with hemoptysis as the initial
symptom: CT and clinical features. Korean J Radiol. 21:537–540.
2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Nitulescu GM, Paunescu H, Moschos SA,
Petrakis D, Nitulescu G, Ion GN, Spandidos DA, Nikolouzakis TK,
Drakoulis N and Tsatsakis A: Comprehensive analysis of drugs to
treat SARS CoV 2 infection: Mechanistic insights into current COVID
19 therapies (Review). Int J Mol Med. 46:467–488. 2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Car-valho F,
Vinceti M, et al: Towards effective COVID 19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
World Health Organization: Coronavirus
Disease 2020 (COVID-19) Pandemic. 16 September, 2020. Available
from: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines.
|
|
60
|
Jones BM, Ma ES, Peiris JS, Wong PC, Ho
JC, Lam B, Lai KN and Tsang KW: Prolonged disturbances of in vitro
cytokine production in patients with severe acute respiratory
syndrome (SARS) treated with ribavirin and steroids. Clin Exp
Immunol. 135:467–473. 2004.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Chien JY, Hsueh PR, Cheng WC, Yu CJ and
Yang PC: Temporal changes in cytokine/chemokine profiles and
pulmonary involvement in severe acute respiratory syndrome.
Respirology. 11:715–722. 2006.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Mahallawi WH, Khabour OF, Zhang Q,
Makhdoum HM and Suliman BA: MERS-CoV infection in humans is
associated with a pro-inflammatory Th1 and Th17 cytokine profile.
Cytokine. 104:8–13. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Liu J, Li S, Liu J, Liang B, Wang X, Wang
H, Li W, Tong Q, Yi J, Zhao L, et al: Longitudinal characteristics
of lymphocyte responses and cytokine profiles in the peripheral
blood of SARS-CoV-2 infected patients. EBioMedicine.
55(102763)2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Stern A, Skalsky K, Avni T, Carrara E,
Leibovici L and Paul M: Corticosteroids for pneumonia. Cochrane
Data-base Syst Rev. 12(CD007720)2017.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Auyeung TW, Lee JS, Lai WK, Choi CH, Lee
HK, Lee JS, Li PC, Lok KH, Ng YY and Wong WM: The use of
corticosteroid as treatment in SARS was associated with adverse
outcomes: A retrospective cohort study. J Infect. 51:98–102.
2005.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Lee N, Allen Chan KC, Hui DS, Ng EK, Wu A,
Chiu RW, Wong VW, Chan PK, Wong KT, Wong E, et al: Effects of early
corticosteroid treatment on plasma SARS-associated Coronavirus RNA
concentrations in adult patients. J Clin Virol. 31:304–309.
2004.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Zhao JP, Hu Y, Du RH, Chen ZS, Jin Y, Zhou
M, Zhang J, Qu JM and Cao B: Expert consensus on the use of
corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua Jie
He He Hu Xi Za Zhi. 43:183–184. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
68
|
Fadel R, Morrison AR, Vahia A, Smith ZR,
Chaudhry Z, Bhargava P, Miller J, Kenney RM, Alangaden G, Ramesh
MS, et al: Early short-course corticosteroids in hospitalized
patients with COVID-19. Clin Infect Dis. 71:2114–2120.
2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Schoot TS, Kerckhoffs AP, Hilbrands LB and
van Marum RJ: Immunosuppressive drugs and COVID-19: A Review. Front
Pharmacol. 11(1333)2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
She Y: Is corticosteroid used or not used
in the treatment of new coronavirus pneumonia? Chin J Crit Care
Intensive Care Med. 6:53–55. 2020.
|
